Neurocrine Biosciences
NBIX
NBIX
122 hedge funds and large institutions have $680M invested in Neurocrine Biosciences in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 45 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $759M → $680M (-$78.5M)
13% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 45
Holders
122
Holding in Top 10
2
Calls
$15.3M
Puts
$10.1M
Top Buyers
| 1 | +$24.3M | |
| 2 | +$22.1M | |
| 3 | +$11.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.97M |
| 5 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$8.83M |
Top Sellers
| 1 | -$9.37M | |
| 2 | -$9.18M | |
| 3 | -$7.85M | |
| 4 |
VM
VHCP Management
New York
|
-$7.85M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$7.77M |